Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes
Article 2023 en
Authors
PK
Paulus Kirchhof
TT
Tobias Toennis
AG
Andreas Goette
Abstract
1 min read
Among patients with AHREs detected by implantable devices, anticoagulation with edoxaban did not significantly reduce the incidence of a composite of cardiovascular death, stroke, or systemic embolism as compared with placebo, but it led to a higher incidence of a composite of death or major bleeding. The incidence of stroke was low in both groups. (Funded by the German Center for Cardiovascular Research and others; NOAH-AFNET 6 ClinicalTrials.gov number, NCT02618577; ISRCTN number, ISRCTN17309850.).
Hans‐Christoph Diener, Nina Becher, Susanne Sehner, Tobias Toennis, Emanuele Bertaglia, Carina Blomström‐Lundqvist, Axel Brandes, Vincent Beuger, Melanie Calvert, A. John Camm, Gregory Chlouverakis, Gheorghe‐Andrei Dan, Wolfgang Dichtl, Alexander Fierenz, Andreas Goette, Joris R. de Groot, Astrid N L Hermans, Professor Gregory Lip, Andrzej Lubiński, Éloi Marijon, Béla Merkely, ,
Jonathan P. Piccini, Manesh R. Patel, Jan Steffel, Keith C. Ferdinand, Isabelle C. Van Gelder, Andrea M. Russo, Chang-Sheng Ma, Shaun G. Goodman, Jonas Oldgren, Christopher Hammett, Renato D. Lópes, Masaharu Akao, Raffaele De Caterina, Paulus Kirchhof, Diana A. Gorog, Martin E W Hemels, Michiel Rienstra, W. Schuyler Jones, Josephine Harrington, Professor Gregory Lip, Stephen J. Ellis, Frank W. Rockhold, Christoph Neumann, John H. Alexander,
Nina Becher, Tobias Toennis, Emanuele Bertaglia, Carina Blomström‐Lundqvist, Axel Brandes, Nuno Cabanelas, Melanie Calvert, A. John Camm, Gregory Chlouverakis, Gheorghe‐Andrei Dan, Wolfgang Dichtl, Hans‐Christoph Diener, Alexander Fierenz, Andreas Goette, Joris R. de Groot, Astrid N L Hermans, Professor Gregory Lip, Andrzej Lubiński, Éloi Marijon, Béla Merkely, Lluı́s Mont, Ann‐Kathrin Ozga, Kim Rajappan, Andrea Sarkozy,
Discussion(0)
No comments yet. Be the first to comment.